Cargando…
Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial
STUDY QUESTION: Do injectable and oral contraceptives increase the risk of human immunodeficiency virus (HIV) acquisition in women? SUMMARY ANSWER: After adjusting for confounders, evidence of a significantly increased risk of HIV remained for women using injectable depo-medroxyprogesterone (DMPA) (...
Autores principales: | Crook, Angela M., Ford, Deborah, Gafos, Mitzy, Hayes, Richard, Kamali, Anatoli, Kapiga, Saidi, Nunn, Andrew, Chisembele, Maureen, Ramjee, Gita, Rees, Helen, McCormack, Sheena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093991/ https://www.ncbi.nlm.nih.gov/pubmed/24838704 http://dx.doi.org/10.1093/humrep/deu113 |
Ejemplares similares
-
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial
por: McCormack, Sheena, et al.
Publicado: (2010) -
Long-term consistent use of a vaginal microbicide gel among HIV-1 sero-discordant couples in a phase III clinical trial (MDP 301) in rural south-west Uganda
por: Abaasa, Andrew, et al.
Publicado: (2013) -
Assessing the Accuracy of Adherence and Sexual Behaviour Data in the MDP301 Vaginal Microbicides Trial Using a Mixed Methods and Triangulation Model
por: Pool, Robert, et al.
Publicado: (2010) -
Uptake of hormonal contraceptives and correlates of uptake in a phase III clinical trial in rural South Western Uganda
por: Abaasa, Andrew, et al.
Publicado: (2017) -
High HIV prevalence and incidence among women in Southern Mozambique: Evidence from the MDP microbicide feasibility study
por: Mocumbi, Sibone, et al.
Publicado: (2017)